News in other languages: Amoéba

02/10	Amoéba : Amoéba organise un webinaire le 7 octobre 2026 à 18h00 pour présenter son augmentation de capital ouverte à tous
02/10	Amoéba : Amoéba veut associer ses actionnaires à sa dernière levée de fonds, avant la monétisation de sa plateforme cosmétique, pour financer son démarrage commercial
25/09	Bourse : les Arnault à la Maison Blanche, HelloFresh avertit et Meta 2000
25/09	Amoéba : Amoéba annonce le succès de la première partie de sa levée de fonds destinée à atteindre l’autonomie financière
25/09	Le Nasdaq tient tête à l'obligataire

More news

Managers and Directors: Amoéba

Manager	Title	Age	Since
Dominique Jean Francois Marie Doucet CEO	Chief Executive Officer	60	14/12/2023
Sandrine Troussieux CTO	Chief Tech/Sci/R&D Officer	-	01/09/2018
Jean-Baptiste Eberst LAW	General Counsel	-	01/07/2015

Director	Title	Age	Since
Valérie Filiatre BRD	Director/Board Member	-	01/06/2014
Benoît Villers CHM	Chairman	70	14/12/2023
Jean-luc Souche BRD	Director/Board Member	70	25/05/2023

More insiders

Amoéba is a greentech company whose ambition is to become a major player in the treatment of microbiological risk based on the patented use of amoebae in the plant protection and cosmetics sectors. With know-how that is unique in the world and protected by numerous patents, Amoéba is currently the only company capable of exploiting the full potential of the Willaertia amoeba on an industrial scale and cultivating it in sufficient volumes to offer biological solutions that constitute a viable alternative to the chemical products widely used today. Amoéba is currently focusing on the global biocontrol market for plant protection and on the cosmetics market.

Employees

Sector

Agricultural Chemicals

More about the company

Quotes

Date	Price	Change	Volume
16/10/26	EUR 0.3100	-0.96%	80,672
15/10/26	EUR 0.3130	-2.19%	63,282
14/10/26	EUR 0.3200	-0.62%	141,759
13/10/26	EUR 0.3220	-1.23%	390,830
12/10/26	EUR 0.3260	+10.70%	1,593,121

Real-time Euronext Paris

More quotes

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.3100EUR

Average target price

1.000EUR

Spread / Average Target

+222.58%

Consensus

EPS Estimates

Evolution of Analysts' Estimates - EPS - Amoéba

Revisions to estimates

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Amoéba

Company calendar

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - Euronext Paris 02:55:00 17/10/26 am AEDT			5-day change	1st Jan Change
0.3100 ^EUR	-0.96%		+5.26%	-70.70%

24/09	Amoéba S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
09/09	Amoéba, Syngenta Sign European Distribution Deal for Biocontrol Fungicide	MT

Market Cap	21.35M 24.02M 19.79M 18.01M 33.98M 2.28B 34.53M 238M 93.28M 1.19B 90.16M 88.24M 3.79B	P/E 2026 *	-4.13x	P/E 2027 *	31x
Enterprise Value	32.5M 36.57M 30.13M 27.41M 51.73M 3.47B 52.55M 362M 142M 1.81B 137M 134M 5.77B	EV / Sales 2026 *	6.37x	EV / Sales 2027 *	2.14x
Free-Float	81.63%	Yield 2026 *	-	Yield 2027 *	-

Markets		Quality
Euronext Paris	ALMIB	Real-time
Börse Stuttgart	A1H	Delayed
Deutsche Boerse AG	A1H	Delayed
Boerse Muenchen	A1H	Real-time

24/09	Amoéba S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
09/09	Amoéba, Syngenta Sign European Distribution Deal for Biocontrol Fungicide	MT
24/07	Amoéba and Koppert Extends Distribution Agreement for Axpera Technology and Reaffirm Their Shared Ambitions in the Field of Innovative Biofungicides	CI
01/07	Amoéba Receives Marketing Authorization For Biofungicide AXPERA In France	CI
01/07	Amoéba gains from marketing authorization in France
30/06	Amoéba Bags Marketing Approval for Biofungicide in France	MT
30/06	Amoéba wins marketing authorization in France
09/06	Amoéba S.A. Obtains 120-Day Emergency Authorization for Use of Biofungicide AXPERA Against Basil Downy Mildew in Italy	CI
09/06	Amoéba secures strategic emergency authorization in Italy
07/05	Amoéba Announces Two New Exceptional Trial Permits for Biocontrol Solution in the Netherlands	CI
29/04	Amoéba Announces Emergency Authorization for Axpera Biocontrol Solution	CI
29/04	Amoéba secures emergency authorization for downy mildew treatment in France
14/04	Amoéba and Koppert Highlight the Potential of Axpera Technology in Brazil for Strategic Crops	CI

Amoéba Stock

Stocks

ALMIB

FR0011051598

Agricultural Chemicals

Valuation: Amoéba

Chart: Amoéba

Latest news: Amoéba

Press Releases: Amoéba

News in other languages: Amoéba

Quotes and Performance

Price Extremes

Managers and Directors: Amoéba

Latest insider transactions

Pesticide

Financials

Company Profile

Quotes

Analysts' Consensus

Annual profits - Rate of surprise

02/10	Amoéba : Amoéba aims to involve its shareholders in its latest fundraising round, ahead of the monetisation of its cosmetics platform, to finance its commercial launch	AT
25/09	Amoéba : Amoéba announces the success of the first phase of its fundraising campaign aimed at achieving financial self-sufficiency	AT
25/09	Amoéba : Amoéba launches a two-phase capital increase expected to be its final market financing before achieving financial self-sufficiency	AT
25/09	Amoéba : Amoéba becomes an industrial and commercial company in biocontrol and initiates a process to monetize its cosmetics asset	AT
10/09	Syngenta and Amoéba Seal Exclusive European Distribution Deal, Aiming to Bring a Breakthrough Biofungicide to Cereal Growers	GL

1 day	-0.96%
1 week	+5.26%
Current month	-2.21%
1 month	-42.59%
3 months	-57.18%
6 months	-64.81%
Current year	-70.70%

1 week	0.3	0.35
1 month	0.28	0.56
Current year	0.28	1.12
1 year	0.28	1.2
3 years	0.28	1.44
5 years	0.28	1.8
10 years	0.28	34.93

Date	Insider	Type	Main position	Quantity	% Market Cap.
30/6/26	Benoît Villers	Sell	Chairman	-31,100	0.0400%
23/5/25	Dominique Jean Francois Marie Doucet	Exercice	Chief Executive Officer	40,000	0.0805%
22/5/25	Dominique Jean Francois Marie Doucet	Exercice	Chief Executive Officer	560,000	1.1277%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AMOÉBA	-0.96%	+5.26%	-71.66%	-22.40%	24.02M
NUTRIEN LTD.	+2.07%	+4.65%	+27.17%	+20.69%	34.01B
QINGHAI SALT LAKE INDUSTRY CO.,LTD	+0.48%	-4.28%	+3.22%	+35.17%	18.24B
CF INDUSTRIES HOLDINGS, INC.	+0.90%	+8.35%	+45.57%	+43.32%	18.29B
SABIC AGRI-NUTRIENTS COMPANY	-1.68%	-4.54%	-9.80%	-17.97%	14.13B
PHOSAGRO	+0.11%	-.--%	-.--%	-.--%	12.96B
YARA INTERNATIONAL ASA	-0.17%	-0.36%	+7.71%	+4.46%	11.12B
JORDAN PHOSPHATE MINES CO. PLC	-0.40%	-3.64%	+12.14%	+174.85%	10.47B
CORTEVA, INC.	0.00%	-2.72%	-	-	8.59B
ACRON	-0.22%	-.--%	-.--%	-.--%	8.3B
Average	+0.13%	+0.77%	+1.59%	+26.46%	13.61B
Weighted average by Cap.	+0.55%	+1.19%	+14.81%	+29.50%

	2026 *	2027 *
Net sales	5.1M 5.74M 4.73M 4.3M 8.12M 545M 8.25M 56.82M 22.28M 284M 21.53M 21.07M 906M	15.55M 17.49M 14.41M 13.11M 24.74M 1.66B 25.14M 173M 67.93M 866M 65.65M 64.26M 2.76B
Net income	-5.2M -5.85M -4.82M -4.39M -8.27M -555M -8.41M -57.93M -22.71M -290M -21.95M -21.49M -924M	550K 619K 510K 464K 875K 58.72M 889K 6.13M 2.4M 30.64M 2.32M 2.27M 97.69M
Net Debt	11.15M 12.54M 10.33M 9.4M 17.74M 1.19B 18.03M 124M 48.71M 621M 47.08M 46.07M 1.98B	11.85M 13.33M 10.98M 9.99M 18.86M 1.27B 19.16M 132M 51.76M 660M 50.03M 48.97M 2.1B